Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple endocrine neoplasia type 2.

Mariola Peczkowska1, Andrzej Januszewicz

  • 1Department of Hypertension, National Institute of Cardiology, Warsaw, Poland. peczpe@chello.pl

Familial Cancer
|May 11, 2005
PubMed
Summary

Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome caused by RET gene mutations. Genetic testing aids early detection and improves outcomes for MEN 2 subtypes like MEN 2A, FMTC, and MEN 2B.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Awareness and Diagnosis: From Knowledge to Action for Blood Pressure Control in Coronary Artery Disease.

European journal of preventive cardiology·2026
Same author

Long-term follow-up after successful multi-stage intravascular repair of acute aortic dissection associated with cocaine exposure.

Polish archives of internal medicine·2026
Same author

Adaptive Optics RTX1 Imaging for Early Detection of Retinal Vascular Remodeling in Hypertensive Retinopathy: A Review.

Journal of clinical medicine·2026
Same author

Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study.

European journal of internal medicine·2026
Same author

The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.

Kardiologia polska·2026
Same author

Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement.

European journal of internal medicine·2026

Area of Science:

  • Genetics
  • Oncology
  • Endocrinology

Background:

  • Multiple Endocrine Neoplasia type 2 (MEN 2) is an autosomal dominant inherited cancer syndrome.
  • Germline mutations in the RET proto-oncogene on chromosome 10q11.2 predispose individuals to MEN 2.
  • MEN 2 encompasses three distinct subtypes: MEN 2A, familial medullary thyroid carcinoma (FMTC), and MEN 2B.

Purpose of the Study:

  • To summarize the clinical characteristics and genetic basis of MEN 2.
  • To highlight the significance of medullary thyroid carcinoma (MTC) across all MEN 2 subtypes.
  • To emphasize the role of genetic testing in early detection and improved prognosis.

Main Methods:

  • Review of existing literature on MEN 2.
  • Analysis of clinical features associated with MEN 2 subtypes.
  • Discussion of the genetic underpinnings of MEN 2.

Main Results:

  • Medullary thyroid carcinoma (MTC) is a hallmark of all MEN 2 subtypes.
  • MEN 2A, the most common form, involves MTC/C-cell hyperplasia, pheochromocytoma, and hyperparathyroidism.
  • MEN 2B is the most aggressive, with early onset and developmental abnormalities; FMTC is characterized solely by MTC.

Conclusions:

  • Genetic testing for RET proto-oncogene mutations is crucial for individuals at high risk.
  • Early detection through genetic testing can lead to improved treatment and prognosis for MEN 2 patients.
  • Understanding the distinct clinical features of MEN 2 subtypes facilitates tailored management strategies.

Related Experiment Videos